Education
About Us
Working with TipRanks
Follow Us
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -43.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -192.40M | $ -84.66M | $ -31.48M | $ -18.73M | $ -2.94M |
| EBITDA | $ -192.36M | $ -84.66M | $ -31.48M | $ -19.38M | $ -3.31M |
| Net Income | $ -177.81M | $ -71.90M | $ -29.80M | $ -19.41M | $ -3.43M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 198.19M | $ 236.57M | $ 110.11M | $ 10.61M | $ 1.41M |
| Total Assets | $ 205.90M | $ 251.64M | $ 114.44M | $ 11.13M | $ 1.49M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 4.50M |
| Net Debt | $ -114.09M | $ -49.30M | $ -87.70M | $ -10.61M | $ 3.09M |
| Total Liabilities | $ 14.65M | $ 10.48M | $ 166.71M | $ 34.05M | $ 5.08M |
| Stockholders' Equity | $ 191.26M | $ 241.15M | $ -52.27M | $ -22.93M | $ -3.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -166.41M | $ -81.17M | $ -29.22M | $ -14.56M | $ -2.46M |
| Operating Cash Flow | $ -166.31M | $ -81.17M | $ -29.22M | $ -14.56M | $ -2.46M |
| Investing Cash Flow | $ 114.96M | $ -160.47M | $ -21.76M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 116.14M | $ 203.25M | $ 128.02M | $ 23.81M | $ 3.83M |